Analysts Dream of $75 While IperionX Stock Stays Stuck in the Dirt

Despite $75-$55 analyst price targets and U.S. government backing, IperionX trades near 2.62 euros, pre-revenue and burning cash as it develops titanium and rare earths.

The gap between where Wall Street thinks IperionX is headed and where it actually trades has rarely been wider. Roth Capital recently set a price target of $75 on the Australian critical-minerals developer, while BTIG followed with a $55 call — both maintain buy ratings. Yet the stock changes hands at just 2.62 euros, roughly 49% below its 52-week high of 5.09 euros and some 21% lower than where it started the year. That chasm captures the tension between a project rich in strategic metals and the cold reality of a pre-revenue miner burning through cash.

The bullish case rests squarely on the feasibility study IperionX released in early June for its titanium, zircon and heavy rare earths project in Camden, Tennessee. The study calculates a post-tax net present value of $813 million and an internal rate of return of nearly 40%. Because the deposit consists of near-surface mineral sands, the company avoids costly blasting and rock crushing. Management plans to develop the operation in two phases with a total capital outlay of about $381 million.

Heavy rare earths such as dysprosium and terbium are critical components in permanent magnets, defense hardware and aerospace applications — making the project a strategic asset for Washington. Since January 2023, the U.S. government has funneled more than $60 million into IperionX. The company recently added a neighboring sand-processing facility for $3 million, a move analyst Neal Dingmann praised for reducing operational risk and offering significant upside.

That government connection runs even deeper. At the end of March, IperionX reported liquidity of $48.2 million, plus roughly $42.1 million in undrawn funds from the U.S. Department of Defense earmarked for reshoring critical supply chains. The Defense Department’s backing underscores the geopolitical value of the company’s technology — particularly its proprietary GenX platform, which promises to replace the energy-intensive Kroll process with a continuous production method that cuts both energy and operating costs.

The GenX system is currently being validated, with results expected in the second half of 2026. A successful validation would unlock a massive capacity expansion at the company’s Virginia Titanium Manufacturing Campus. That facility is already running 24/7, targeting 200 tonnes of annual production by the end of this year, with a later ramp-up to 1,400 tonnes — seven times the initial output.

Meanwhile, IperionX posted a quarterly loss of nearly $35 million, a reminder that it remains entirely dependent on external financing. The company’s own target of achieving positive EBITDA by the end of 2026 is the key milestone that investors are watching. Texas Capital Securities, which initiated coverage with a buy rating last Tuesday, helped trigger a 10% one-day bounce in the shares to 2.62 euros, but that gain did little to close the gap to the 50-day moving average of 2.97 euros.

For the bears, the math is simple: no revenue, deep losses and a stock that has shed a fifth of its value this year. For the bulls, the story is about a rare earths project with triple-digit target prices, Pentagon dollars and a technology that could reshape titanium production. Management tried to tip the scales at the end of March, when four insiders bought more than $2 million worth of shares on the open market — two of them for the first time. That vote of confidence says loud and clear that the people closest to the operation believe the dirt in Tennessee is worth far more than the market currently assigns.